News
Biotech cools off in August as capital markets weaken September 01, 2010 | Press Release
Biotech gets hot in July August 02, 2010 | Press Release
Shawn Cross appointed CEO of Burrill Merchant Banking Group July 28, 2010 | Press Release
See all News
G. Steven Burrill
Chief Executive Officer
Bryant E. Fong
Managing Director
Ann F. Hanham
Managing Director
Michael Keyoung, MD, PhD
Managing Director, Burrill Pan-Asia
Marietta Wu
Director, China/Taiwan
Greater China, with its tremendous cost advantages, a rapidly growing domestic market, and a quickly advancing science and technology base, is becoming an important force in the global life sciences industry. With the improved relationship and increased regulatory harmonization trend between Mainland China and Taiwan, Taiwan is in a unique position to be the perfect launching pad to access opportunities in the region. Burrill & Company, with its vision that Greater China is becoming a leading global pharmaceutical development and manufacturing center, has established the Burrill Greater China (BGC) team to bridge the life sciences industries in the Greater China region and the Western world. BGC leverages its network and resources in both sides of the Pacific to capture China/Taiwan-related venture capital investing and merchant banking opportunities.
![]() |
Contact: Marietta Wu
|

